Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions-Reference-Cited by-同舟云学术

Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions

Published:2000-04 Issue:2 Volume:25 Page:131-137
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Akhondzadeh ,Shasavand ,Jamilian ,Shabestari ,Kamalipour

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2710.2000.00273.x/fullpdf

Reference45 articles.

1. The glutamate hypothesis of schizophrenia

2. Recent advances in the pharmacotherapy of schxzophrenia

3. 4. P Deniker . (1970 ) Introduction of neuroleptic chemotherapy into psychiatry . In: Ayd F, Balckwell B. eds.Discoveries in Biological PsychiatryPhiladelphia: J. B. Lippincott Company, 155164.

4. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Impacts of Diet, Supplementation, Microbiota, Gut–Brain Axis on Schizophrenia: A Narrative Review;Nutrients;2024-07-11

2. Novel pharmacotherapy targeting the positive symptoms of schizophrenia;Expert Opinion on Pharmacotherapy;2023-07-10

3. Molecular and Structural Insight into Adenosine A2A Receptor in Neurodegenerative Disorders: A Significant Target for Efficient Treatment Approach;Molecular Neurobiology;2023-06-30

4. The adenosine hypothesis of schizophrenia into its third decade: From neurochemical imbalance to early life etiological risks;Frontiers in Cellular Neuroscience;2023-03-14

5. Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?;International Journal of Molecular Sciences;2022-10-05